$PHIO·4

RXi Pharmaceuticals Corp · Feb 12, 8:47 PM ET

RXi Pharmaceuticals Corp 4

4 · RXi Pharmaceuticals Corp · Filed Feb 12, 2016

Insider Transaction Report

Form 4
Period: 2016-02-10
Pavco Pamela
Chief Development Officer
Transactions
  • Award

    Stock option (right to buy)

    2016-02-10+66,00066,000 total
    Exercise: $0.29Exp: 2026-02-10Common stock (66,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION